Literature DB >> 2416955

Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.

J Colicelli, S P Goff.   

Abstract

We have previously described the construction of a mutant of Moloney murine leukemia virus bearing a deletion at the normal site of integration of the viral DNA. We have now recovered a revertant of the virus after abortive infection of mouse cells and have determined the structure of the new virus. The revertant is a recombinant virus containing a 500-base-pair patch of new sequences derived from the mouse genome. The integration site was perfectly restored to the wild-type sequence, although the patch of DNA was overall only 80% homologous to Moloney murine leukemia virus. Surprisingly, the tRNA primer binding site was no longer homologous to the usual proline tRNAs, but was a perfect match for glutamine tRNA. This result suggests that the Moloney murine leukemia virus reverse transcriptase is not specific to one tRNA, but can utilize different tRNAs to prime the synthesis of viral DNA. Comparisons with published reports allowed the identification of sequences that are 94% homologous to the patch sequence, present in one of the endogenous retroviral sequences of the mouse. No replication-competent members of this family, utilizing the glutamine tRNA primer, have been previously isolated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416955      PMCID: PMC252696     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences.

Authors:  L I Lobel; S P Goff
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair.

Authors:  P Schwartzberg; J Colicelli; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses.

Authors:  R A Weiss; W S Mason; P K Vogt
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Nucleotide sequence of acceptor site and termini of integrated avian endogenous provirus ev1: integration creates a 6 bp repeat of host DNA.

Authors:  F Hishinuma; P J DeBona; S Astrin; A M Skalka
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  DNA methylation affecting the expression of murine leukemia proviruses.

Authors:  J W Hoffmann; D Steffen; J Gusella; C Tabin; S Bird; D Cowing; R A Weinberg
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic leukemia virus-related DNA clone.

Authors:  C Y Ou; L R Boone; W K Yang
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

View more
  58 in total

1.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4.

Authors:  C Modin; F S Pedersen; M Duch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.

Authors:  Nathan J Kelly; Matthew T Palmer; Casey D Morrow
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 6.  Retrons and multicopy single-stranded DNA.

Authors:  M Inouye; S Inouye
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

7.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys.

Authors:  Z Zhang; Q Yu; S M Kang; J Buescher; C D Morrow
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.

Authors:  P B Robbins; D C Skelton; X J Yu; S Halene; E H Leonard; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.